BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8265887)

  • 1. Different characteristics of neuroblastomas in cases found by mass screening and non-screening: evaluation of mass screening for neuroblastoma in Kitakyushu City.
    Ariyoshi N
    J UOEH; 1993 Dec; 15(4):251-66. PubMed ID: 8265887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
    J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
    Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroblastoma of the urinary bladder, preclinically detected by mass screening.
    Yokoyama S; Hirakawa H; Ueno S; Yabe H; Hiraoka N
    Pediatrics; 1999 May; 103(5):e67. PubMed ID: 10224211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
    Takeuchi LA; Hachitanda Y; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD
    Cancer; 1995 Dec; 76(11):2363-71. PubMed ID: 8635044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
    Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
    Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M
    Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan.
    Tajiri T; Suita S; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Handa N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M;
    Cancer; 2001 Jul; 92(2):349-53. PubMed ID: 11466689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J
    J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maturation of mass-screened localized adrenal neuroblastoma.
    Iwanaka T; Yamamoto K; Ogawa Y; Arai M; Ito M; Kishimoto H; Hanada R; Imaizumi S
    J Pediatr Surg; 2001 Nov; 36(11):1633-6. PubMed ID: 11685689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors.
    Kerbl R; Urban CE; Ambros IM; Dornbusch HJ; Schwinger W; Lackner H; Ladenstein R; Strenger V; Gadner H; Ambros PF
    J Clin Oncol; 2003 Nov; 21(22):4228-34. PubMed ID: 14615452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in prognosis of neuroblastoma through mass population screening.
    Naito H; Sasaki M; Yamashiro K; Takeda T; Takasugi N; Uchino J; Hata Y
    J Pediatr Surg; 1990 Feb; 25(2):245-8. PubMed ID: 2303994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study.
    Kaneko Y; Kanda N; Maseki N; Nakachi K; Takeda T; Okabe I; Sakurai M
    J Clin Oncol; 1990 Dec; 8(12):2005-13. PubMed ID: 2230892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to deal with advanced cases of neuroblastoma detected by mass screening: a report from the Pediatric Oncology Study Group of the Kyushu area of Japan.
    Suita S; Zaizen Y; Yano H; Akiyama H; Sera Y; Takamatsu H; Ueda K; Tasaka H; Miyazaki S; Kawakami K
    J Pediatr Surg; 1994 May; 29(5):599-603. PubMed ID: 8035266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results for 79 patients with neuroblastoma detected through mass screening at 6 months of age in a single institute.
    Nishio N; Mimaya J; Nara T; Takashima Y; Horikoshi Y; Urushihara N; Hasegawa S; Aoki K; Hamasaki M
    Pediatr Int; 2006 Dec; 48(6):531-5. PubMed ID: 17168969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high level of hCDC10 gene expression in neuroblastoma may be associated with favorable characteristics of the tumor.
    Nagata T; Takahashi Y; Asai S; Ishii Y; Mugishima H; Suzuki T; Chin M; Harada K; Koshinaga S; Ishikawa K
    J Surg Res; 2000 Aug; 92(2):267-75. PubMed ID: 10896833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One hundred neuroblastomas detected through a mass screening system in Japan.
    Hachitanda Y; Ishimoto K; Hata J; Shimada H
    Cancer; 1994 Dec; 74(12):3223-6. PubMed ID: 7982186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
    Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology review of screening negative neuroblastomas: a report from the Quebec Neuroblastoma Screening Project.
    Kawakami T; Monobe Y; Monforte H; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD; Triche TJ; Shimada H
    Cancer; 1998 Aug; 83(3):575-81. PubMed ID: 9690552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.